Related Experiment Videos
Caffeine restriction as initial treatment for breast pain
1Department of Surgery, Duke University Medical Center, Durham, N.C.
The Nurse Practitioner
|February 1, 1989
Summary
Reducing caffeine intake significantly decreased breast pain in most patients with fibrocystic breast disease. This study highlights caffeine restriction as an effective management strategy for this common condition.
Area of Science:
- Medical Science
- Clinical Nutrition
Background:
- Fibrocystic breast disease is a common condition characterized by breast pain.
- Methylxanthines, including caffeine, theophylline, and theobromine, are suspected contributors to these symptoms.
Purpose of the Study:
- To investigate the impact of methylxanthine consumption on fibrocystic breast disease symptoms.
- To evaluate the efficacy of caffeine restriction in managing breast pain associated with fibrocystic breast disease.
Main Methods:
- A study involving 147 patients diagnosed with fibrocystic breast disease and experiencing breast pain.
- Patients reported caffeine consumption levels (light, moderate, heavy) and pain severity (mild, moderate, severe).
- Participants were advised to reduce or abstain from caffeine for one year.
Main Results:
- High compliance with caffeine reduction was observed in 81.9% of patients.
- A significant decrease or absence of breast pain was reported by 61% of patients who reduced caffeine intake.
- The findings support a correlation between caffeine consumption and fibrocystic breast pain.
Conclusions:
- Caffeine restriction is an effective non-pharmacological approach for managing breast pain in fibrocystic breast disease.
- Reducing intake of methylxanthine-containing products can lead to symptom improvement.
- Further research can explore personalized dietary interventions for breast pain management.